These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Value of the peak expiratory flow in bronchodynamic tests. Pino JM, García-Río F, Prados C, Alvarez-Sala R, Díaz S, Villasante C, Villamor J. Allergol Immunopathol (Madr); 1996; 24(2):54-7. PubMed ID: 8933890 [Abstract] [Full Text] [Related]
7. Prevalence and reversibility of lower airway obstruction in children with sickle cell disease. Koumbourlis AC, Zar HJ, Hurlet-Jensen A, Goldberg MR. J Pediatr; 2001 Feb; 138(2):188-92. PubMed ID: 11174615 [Abstract] [Full Text] [Related]
10. Pulmonary function abnormalities in thalassemia patients on a hypertransfusion program. Keens TG, O'Neal MH, Ortega JA, Hyman CB, Platzker AC. Pediatrics; 1980 May; 65(5):1013-7. PubMed ID: 7367114 [Abstract] [Full Text] [Related]
11. Use of pulmonary function tests in the assessment and treatment of patients with airway hyperreactivity. Cherniack RM. Clin Rev Allergy; 1985 Oct; 3(4):395-409. PubMed ID: 3931893 [Abstract] [Full Text] [Related]
14. Relationship between airway responsiveness and peak expiratory flow variability in subjects with allergic rhinitis. Prieto L, Gutiérrez V, Bertó JM, Tornero C, Camps B, Pérez MJ. Ann Allergy Asthma Immunol; 1995 Sep; 75(3):273-9. PubMed ID: 7552931 [Abstract] [Full Text] [Related]
15. Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis. Tirimanna PR, Den Otter JJ, Van Schayck CP, Van Herwaarden CL, Folgering H, Van Weel C. Br J Gen Pract; 1996 Jan; 46(402):15-8. PubMed ID: 8745846 [Abstract] [Full Text] [Related]